Skip Nav Destination

Issue Archive

Select Year

Issue

Volume 18, Issue 1

January-February 2021

In this Issue

Ask the Cardiologists
Ask the Hematologist
Features
Headlines from Washington
President’s Column
Year's Best

Ask the Cardiologists

Diagnosing Amyloid Light-Chain Amyloidosis: A Cardiovascular Emergency

Jose A. Alvarez-Cardona, MD, FACC,Daniel J. Lenihan, MD, FACC

View Articletitled, Diagnosing Amyloid Light-Chain Amyloidosis: A Cardiovascular Emergency

Ask the Hematologist

Predicting and Managing Toxicities of Chimeric Antigen Receptor T-cell Therapy in Large B-cell Lymphoma

Frederick Locke, MD

View Articletitled, Predicting and Managing Toxicities of Chimeric Antigen Receptor T-cell Therapy in Large B-cell Lymphoma

Features

#ASH20: An Unconventionally Conventional Meeting

Ahmar U. Zaidi, MD

View Articletitled, #ASH20: An Unconventionally Conventional Meeting

Headlines from Washington

Hematology Advocacy Doesn’t Skip a Beat With New Congress and Administration

ASH STAFF

View Articletitled, Hematology Advocacy Doesn’t Skip a Beat With New Congress and Administration

President’s Column

Opportunities Abound

Martin S. Tallman, MD

View Articletitled, Opportunities Abound

Year's Best

A New Target for B-ALL CAR-T

Caroline Diorio, MD,David T. Teachey, MD

View Articletitled, A New Target for B-ALL CAR-T

Big Questions in 2020: Single-cell Sequencing in Myeloid Malignancies Brings Us Closer to Answers

Amy DeZern, MD, MHS

View Articletitled, Big Questions in 2020: Single-cell Sequencing in Myeloid Malignancies Brings Us Closer to Answers

The BELLINI Study and the Dawn of Precision Medicine in Multiple Myeloma

Mark Bustoros, MD,Irene M. Ghobrial, MD

View Articletitled, The BELLINI Study and the Dawn of Precision Medicine in Multiple Myeloma

Not All TP53 Mutations Are Equal

Yatika Jivan, MBBS, FRACP,Steven Lane, MBBS, PhD, FRACP, FRCPA

View Articletitled, Not All <em>TP53</em> Mutations Are Equal

Anticoagulation Versus Antiplatelet Therapy: The Emerging Role for Fixed Low-dose Anticoagulants in Arterial Disease

Damon Houghton, MD

View Articletitled, Anticoagulation Versus Antiplatelet Therapy: The Emerging Role for Fixed Low-dose Anticoagulants in Arterial Disease

A New CAR-T Option for Mantle Cell Lymphoma

Brad Kahl, MD

View Articletitled, A New CAR-T Option for Mantle Cell Lymphoma

Complement and Thrombosis: What Is, and What Might Be

Eric Tseng, MD, MScCH, FRCPC

View Articletitled, Complement and Thrombosis: What Is, and What Might Be

We Have More in Common Than What Sets Us Apart: Shared Founding Drivers in Myeloid Neoplasms and T-cell Lymphomas

Mark G. Evans, MD,Annette S. Kim, MD, PhD

View Articletitled, We Have More in Common Than What Sets Us Apart: Shared Founding Drivers in Myeloid Neoplasms and T-cell Lymphomas

Clonal Selection of Mutant HSC in MPN: “What Do I Know?”

Ruggiero Norfo, PhD,Adam Mead, MD, PhD

View Articletitled, Clonal Selection of Mutant HSC in MPN: “What Do I Know?”

The Year’s Best in Sickle Cell Disease

Seethal Jacob, MD, MS, FAAP,Julie Kanter, MD

View Articletitled, The Year’s Best in Sickle Cell Disease

T-Cell Battle Royale: Chimeric Antigen Receptor T-cells for the Treatment of T-lineage Acute Lymphoblastic Leukemia

Jozal W. Moore, MD,Kristen M. O’Dwyer, MD

View Articletitled, T-Cell Battle Royale: Chimeric Antigen Receptor T-cells for the Treatment of T-lineage Acute Lymphoblastic Leukemia

Things Done Right in 2020

Laura C. Michaelis, MD

View Articletitled, Things Done Right in 2020

Cover Image

Cover Image

All Issues

Advertisement intended for health care professionals

Email alerts

Latest Issue Alert

Continuous Publishing Alert

New Journal Content Alert

Latest
Most Read

Vitamin A to Keep GVHD Away: Single Oral High-Dose Vitamin A Before Bone Marrow Transplant Reduces Graft-Versus-Host Disease in Pediatric and Young Adult Patients

Trainee Corner
A Career in Academia: Should I Stay or Should I Go?

Then and Now
Treatment for Acute Leukemia in Older Adults: Two Decades of Remarkable Progress

Does Sustained Monocytosis Always Mean CMML? A Case of Ras-Associated Autoimmune Leukoproliferative Disorder

ASH and Federal Officials Hold Town Hall on Sickle Cell Disease

Advertisement intended for health care professionals

Table of Contents

Ask the Cardiologists

Diagnosing Amyloid Light-Chain Amyloidosis: A Cardiovascular Emergency

Ask the Hematologist

Predicting and Managing Toxicities of Chimeric Antigen Receptor T-cell Therapy in Large B-cell Lymphoma

Features

#ASH20: An Unconventionally Conventional Meeting

Headlines from Washington

Hematology Advocacy Doesn’t Skip a Beat With New Congress and Administration

President’s Column

Opportunities Abound

Year's Best

A New Target for B-ALL CAR-T

Big Questions in 2020: Single-cell Sequencing in Myeloid Malignancies Brings Us Closer to Answers

The BELLINI Study and the Dawn of Precision Medicine in Multiple Myeloma

Not All TP53 Mutations Are Equal

Anticoagulation Versus Antiplatelet Therapy: The Emerging Role for Fixed Low-dose Anticoagulants in Arterial Disease

A New CAR-T Option for Mantle Cell Lymphoma

Complement and Thrombosis: What Is, and What Might Be

We Have More in Common Than What Sets Us Apart: Shared Founding Drivers in Myeloid Neoplasms and T-cell Lymphomas

Clonal Selection of Mutant HSC in MPN: “What Do I Know?”

The Year’s Best in Sickle Cell Disease

T-Cell Battle Royale: Chimeric Antigen Receptor T-cells for the Treatment of T-lineage Acute Lymphoblastic Leukemia

Things Done Right in 2020

Email alerts

ASH Publications

American Society of Hematology

Issue Archive

Table of Contents

Ask the Cardiologists

Ask the Hematologist

Features

Headlines from Washington

President’s Column

Year's Best

Cover Image

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only